The DOI matches its Crossref record.
American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients With Suspected or Confirmed COVID-19 Infection
Open accessAbstract
To the Editor: Considering the global spread of COVID-19 infection and the increased number of confirmed COVID-19 cases across the United States, the American Association for Bronchology and Interventional Pulmonology (AABIP) is issuing this statement on the safe and effective use of bronchoscopy in patients with suspected or confirmed COVID-19 infection. The main purpose of this statement is to ensure the safety of our patients, health care team and community at large. We are releasing these urgent recommendations to guide clinicians around the world with the understanding that new information may subsequently modify or impact these current recommendations. We will strive to update this statement as needed in a timely fashion. This document is based on the latest Centers for Disease Control (CDC) recommendations March 9, 2020 and expert consensus of the AABIP COVID-19 Task Force. General Recommendations for collection of respiratory specimen collection for suspected COVID-191–4: Collection of upper respiratory samples via nasopharyngeal and oropharyngeal swabs is the primary and preferred method for diagnosis. Respiratory specimen collection is recommended in suspected COVID-19 regardless of time of onset of symptoms. Induced sputum collection is NOT recommended. Because it is an aerosol generating procedure that poses substantial risk to patients and staff, bronchoscopy should have an extremely limited role in the diagnosis of COVID-19 and only be considered in intubated patients if upper respiratory samples are negative and other diagnosis is considered that would significantly change clinical management. Alternative respiratory specimen collection in the intubated patient can include tracheal aspirates and nonbronchoscopic alveolar lavage. If bronchoscopy is being performed for COVID-19 sample collection, a minimum of 2-3 mL of specimen into a sterile, leak proof container for specimen collection is recommended.4 Only essential personnel should be present when performing any specimen collection. Alert laboratory personnel regarding COVID-19 specimen processing and testing. Additional Considerations for Respiratory Evaluation: Constellation of fever, respiratory symptoms, and radiographic evidence of ground glass opacities and pneumonitis should raise clinical suspicion of COVID-19.5,6 Patients demonstrating such symptoms or findings should be queried about personal history of recent travel to any country with a CDC level 2 or higher travel warning (currently China, Italy, Iran, South Korea, and Japan), contact with a confirmed COVID-19 person or contact with others with such travel history. Clinicians should consider the local prevalence of COVID-19 cases when evaluating the clinical risk for COVID-19 infection, understanding that a travel or exposure history will become increasingly ineffective in identifying patients at risk for infection. Guidelines for respiratory and contact isolation should be followed in all known or suspected cases of COVID-19 infections. Evaluate for influenza and respiratory syncytial virus as well as other respiratory pathogens and additional diagnoses as clinically indicated. For all suspected COVID-19 cases notify internal institutional infection control personnel and state or local public health department. General Personnel Preparation if Bronchoscopy is needed in patients with suspected or confirmed COVID-19 infection: Place patient in Airborne Infection Isolation Room negative pressure room isolation. All personnel should wear a powered, Air-Purifying Respirator or N95 mask and eye protection. All personnel should wear standard Personal Protective Equipment which includes gown, gloves, respiratory protection, and eye protection. Follow CDC instructions for proper donning and doffing of all protective equipment and disposable devices (www.cdc.gov/hai/prevent/ppe.html). Disposable bronchoscopes should be used first line when available. Follow standard disinfection protocol of durable reusable video monitors. Follow standard high-level disinfection for reusable bronchoscopes. Limit to essential medical personnel during the procedure and specimen collection. General Precautions for performing non-urgent bronchoscopy among patients WITHOUT suspected COVID-19 infection: All patients presenting for previously scheduled bronchoscopy should be asked about their recent travel history before entering the bronchoscopy suite. Bronchoscopy should be postponed if the patient has a history of recent travel to any country with a CDC level 2 or higher travel warning (currently China, Italy, Iran, South Korea, and Japan). All patients should be asked about any fever or ongoing infectious or respiratory symptoms before bronchoscopy. Procedures should be postponed if possible until such symptoms have resolved or testing (if available) is negative. If procedures cannot be postponed as determined by the clinical indication, the procedure should be performed using the precautions as outlined a
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Co-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619
Koehler, P., Bassetti, M., Chakrabarti, A., Chen, S. C. A., Colombo, A. L., Hoenigl, M., Klimko, N., Lass-Flörl, C., Oladele, R. O., Vinh, D. C., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30847-1 · Cited by 951
Halpin, D. M. G., Criner, G. J., Papi, A., Singh, D., Anzueto, A., Martinez, F. J., Agusti, A. A., & Vogelmeier, C. F. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3533so · Cited by 760
SARS-CoV-2 detection, viral load and infectivity over the course of an infection
Walsh, K. A., Jordan, K., Clyne, B., Rohde, D., Drummond, L., Byrne, P., Ahern, S., Carty, P. G., O'Brien, K. K., O'Murchu, E., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.06.067 · Cited by 608
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Arastehfar, A., Carvalho, A., van de Veerdonk, F. L., Jenks, J. D., Koehler, P., Krause, R., Cornely, O. A., S. Perlin, D., Lass-Flörl, C., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6020091 · Cited by 421
Metadata
- Authors
- Wahidi, M. M., Lamb, C., Murgu, S., Musani, A., Shojaee, S., Sachdeva, A., Maldonado, F., Mahmood, K., Kinsey, M., Sethi, S., Mahajan, A., Majid, A., Keyes, C., Alraiyes, A. H., Sung, A., Hsia, D., & Eapen, G.
- Venue
- Journal of Bronchology & Interventional Pulmonology
- Published
- 2020-09-23
- Volume
- 27
- Issue
- 4
- Pages
- e52-e54
- ISSN
- 1944-6586 (ISSN-L)
- OpenAlex
- W3012299769
- Cited by
- 230
- References
- 0
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients With Suspected or Confirmed COVID-19 Infection. https://app.cochat.ai/papers/10.1097/lbr.0000000000000681
- The paper
- Wahidi, M. M., Lamb, C., Murgu, S., Musani, A., Shojaee, S., Sachdeva, A., Maldonado, F., Mahmood, K., Kinsey, M., Sethi, S., Mahajan, A., Majid, A., Keyes, C., Alraiyes, A. H., Sung, A., Hsia, D., & Eapen, G. (2020). American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients With Suspected or Confirmed COVID-19 Infection. Journal of Bronchology & Interventional Pulmonology. https://doi.org/10.1097/lbr.0000000000000681
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.